GB1492383A - Therapeutic composition - Google Patents
Therapeutic compositionInfo
- Publication number
- GB1492383A GB1492383A GB1181374A GB1181374A GB1492383A GB 1492383 A GB1492383 A GB 1492383A GB 1181374 A GB1181374 A GB 1181374A GB 1181374 A GB1181374 A GB 1181374A GB 1492383 A GB1492383 A GB 1492383A
- Authority
- GB
- United Kingdom
- Prior art keywords
- virus
- immunoglobulins
- viral
- march
- dry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 3
- 102000018358 immunoglobulin Human genes 0.000 abstract 3
- 229940072221 immunoglobulins Drugs 0.000 abstract 3
- 241000700605 Viruses Species 0.000 abstract 2
- 230000000840 anti-viral effect Effects 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 abstract 1
- 201000006082 Chickenpox Diseases 0.000 abstract 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 abstract 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 abstract 1
- 241000700626 Cowpox virus Species 0.000 abstract 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 abstract 1
- 102000014150 Interferons Human genes 0.000 abstract 1
- 108010050904 Interferons Proteins 0.000 abstract 1
- 206010046980 Varicella Diseases 0.000 abstract 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 abstract 1
- 229960003805 amantadine Drugs 0.000 abstract 1
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 229940088710 antibiotic agent Drugs 0.000 abstract 1
- 239000003443 antiviral agent Substances 0.000 abstract 1
- 229960004544 cortisone Drugs 0.000 abstract 1
- 239000006071 cream Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003885 eye ointment Substances 0.000 abstract 1
- 239000006260 foam Substances 0.000 abstract 1
- 229960004716 idoxuridine Drugs 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 229940079322 interferon Drugs 0.000 abstract 1
- 239000006210 lotion Substances 0.000 abstract 1
- 239000008267 milk Substances 0.000 abstract 1
- 210000004080 milk Anatomy 0.000 abstract 1
- 235000013336 milk Nutrition 0.000 abstract 1
- 239000002324 mouth wash Substances 0.000 abstract 1
- 229940051866 mouthwash Drugs 0.000 abstract 1
- 239000002674 ointment Substances 0.000 abstract 1
- 229940069265 ophthalmic ointment Drugs 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000725 suspension Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
- 230000003612 virological effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
- C07K16/085—Herpetoviridae, e.g. pseudorabies virus, Epstein-Barr virus
- C07K16/087—Herpes simplex virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1181374A GB1492383A (en) | 1974-03-16 | 1974-03-16 | Therapeutic composition |
| FR7506548A FR2263784B1 (en, 2012) | 1974-03-16 | 1975-03-03 | |
| NL7502628A NL7502628A (nl) | 1974-03-16 | 1975-03-05 | Werkwijze ter bereiding van therapeutische preparaten. |
| BE154374A BE826730A (fr) | 1974-03-16 | 1975-03-14 | Medicaments a base de globulines anti-virales specifiques, notamment anti-herpetique, destines a l'usage externe |
| DE19752511283 DE2511283A1 (de) | 1974-03-16 | 1975-03-14 | Therapeutische zusammensetzung |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1181374A GB1492383A (en) | 1974-03-16 | 1974-03-16 | Therapeutic composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1492383A true GB1492383A (en) | 1977-11-16 |
Family
ID=9993165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1181374A Expired GB1492383A (en) | 1974-03-16 | 1974-03-16 | Therapeutic composition |
Country Status (5)
| Country | Link |
|---|---|
| BE (1) | BE826730A (en, 2012) |
| DE (1) | DE2511283A1 (en, 2012) |
| FR (1) | FR2263784B1 (en, 2012) |
| GB (1) | GB1492383A (en, 2012) |
| NL (1) | NL7502628A (en, 2012) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3417406A1 (de) * | 1984-05-10 | 1986-01-02 | Gödecke AG, 1000 Berlin | Antiserum gegen hepatitis b-oberflaechenantigen aus schaf, pferd oder ziege und verfahren zu seiner herstellung |
| GB2160771A (en) * | 1984-06-28 | 1986-01-02 | Lion Corp | Composition for oral application |
| EP2248825A1 (en) * | 2009-05-04 | 2010-11-10 | Ribovax Biotechnologies SA | Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases |
-
1974
- 1974-03-16 GB GB1181374A patent/GB1492383A/en not_active Expired
-
1975
- 1975-03-03 FR FR7506548A patent/FR2263784B1/fr not_active Expired
- 1975-03-05 NL NL7502628A patent/NL7502628A/xx not_active Application Discontinuation
- 1975-03-14 DE DE19752511283 patent/DE2511283A1/de not_active Withdrawn
- 1975-03-14 BE BE154374A patent/BE826730A/xx unknown
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3417406A1 (de) * | 1984-05-10 | 1986-01-02 | Gödecke AG, 1000 Berlin | Antiserum gegen hepatitis b-oberflaechenantigen aus schaf, pferd oder ziege und verfahren zu seiner herstellung |
| GB2160771A (en) * | 1984-06-28 | 1986-01-02 | Lion Corp | Composition for oral application |
| US4714612A (en) * | 1984-06-28 | 1987-12-22 | Lion Corporation | Composition for oral application |
| EP2248825A1 (en) * | 2009-05-04 | 2010-11-10 | Ribovax Biotechnologies SA | Antigen binding fragments of an antibody for use in treating and diagnosing ocular diseases |
| WO2010128053A1 (en) * | 2009-05-04 | 2010-11-11 | Ribovax Biotechnologies Sa | Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases |
| US8747856B2 (en) | 2009-05-04 | 2014-06-10 | Ribovax Biotechnologies S.A. | Antigen binding fragments of an antibody for use in treating or diagnosing ocular diseases |
Also Published As
| Publication number | Publication date |
|---|---|
| NL7502628A (nl) | 1975-09-18 |
| DE2511283A1 (de) | 1975-09-18 |
| FR2263784B1 (en, 2012) | 1978-07-28 |
| BE826730A (fr) | 1975-06-30 |
| FR2263784A1 (en, 2012) | 1975-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO140301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner | |
| CA1029303A (en) | Method of contraception by the administration of stage-combination preparations | |
| IT1026022B (it) | Base topica farmaceutica per creme | |
| IE42340L (en) | 11,12-secoprostaglandins | |
| JPS5699412A (en) | Rosemary aciddcontaining pharmaceutic product | |
| GB1503675A (en) | Compositions based on pyrimidine derivatives and their use in the treatment of viral infections | |
| CA1016464A (en) | Shampoo conditioner formulations | |
| GB1492383A (en) | Therapeutic composition | |
| IE37717B1 (en) | N-benzhydryl-n'-p-hydroxybenzyl-piperazines and processes for their manufacture | |
| NO740614L (no) | Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser. | |
| EG11829A (en) | The introduction of (o-ch3)group to olefin in it's gases stage | |
| IE39192B1 (en) | Novel steroids of the oestrane series substituted in 7-po | |
| ZA742728B (en) | Pharmaceutical composition for the treatment of coronaric ailments | |
| AU7540474A (en) | Novel shampoo composition | |
| MX144082A (es) | Composicion de champu acondicionadora no irritante | |
| ZA744750B (en) | 16-methyl-pregna-1,4,9 (11)-triene-3,20-diones as medicaments- new processes for the preparation of these products, and pharmaceutical compositions | |
| CA944688A (en) | Certain diphenyl sulfones in the treatment of marek's disease | |
| NO741309L (no) | Analogifremgangsmåte ved fremstilling av terapeutisk aktive seco-prostaglandiner. | |
| IE39885B1 (en) | Diphenylimidazolidines and their pharmaceutical compositons | |
| GB1177009A (en) | Improvements in or relating to 9alpha, 11beta-Dichloro-Pregnane Compounds | |
| NO142398C (no) | Tiofenderivater for anvendelse som mellomprodukter ved fremstilling av terapeutisk aktive aminoalkylestere av alfa-substituert (3-tienyl)-eddiksyre | |
| IE39714L (en) | N-imidazolylethylcarbamates | |
| GB1153767A (en) | Improvements in or relating to Amitotic Therapeutic Composition Administrable by the Topical Route | |
| SE7801062L (sv) | Nya mellanprodukter for framstellning av terapeutiskt aktiva foreningar | |
| CA763405A (en) | Process for the manufacture of pharmaceutical preparations in bead form |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |